Online Trial Tracker - Larvol Sigma

MIL95 / Beijing Mabworks Biotech, Keymed Biosciences

Welcome, Profile Billing Logout

1 Trials

All TrialsIndustry lead sponsorIndustry collaboratorPhase 1

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

MIL95 / Beijing Mabworks Biotech, Keymed Biosciences

NCT04651348: A Clinical Study of MIL95 in Advanced Malignancies.

Recruiting

RoW

Recombinant Humanized Monoclonal Antibody MIL95

Beijing Mabworks Biotech Co., Ltd.

Advanced Malignancies

12/22

11/24

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites